Home
/

What is a CRP / Albumin Ratio Blood Test?

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Quick answer:

The CRP/Albumin Ratio (CAR) amplifies inflammatory signals by combining CRP (which rises with inflammation) and albumin (which falls during acute stress), creating a marker of systemic inflammatory burden relative to physiological reserve. Healthy individuals show very low ratios, while high CAR is associated with severe infections, autoimmune flares, cancer burden, and cardiovascular risk. CAR is most informative when tracked alongside individual CRP, albumin, CBC, and liver tests.

Read more →
Table of contents

Two liver-made proteins moving in opposite directions

The CRP/Albumin Ratio (CAR) is a blood test calculation that compares two liver-made blood proteins. C-reactive protein (CRP) is released by the liver when the immune system detects inflammation or tissue damage. Serum albumin (albumin) is the most abundant protein in the bloodstream, produced by liver cells and responsible for maintaining fluid balance and carrying hormones, fatty acids, and drugs. Because both CRP and albumin are synthesized in the liver (hepatocytes) and circulate in plasma, their ratio captures a linked biological response at its source.

CAR reflects how strongly the body is mounting an acute defense versus maintaining its baseline protein economy. During the acute-phase response, CRP rises rapidly (positive acute-phase reactant), while albumin typically falls as the liver shifts priorities and proteins move out of the circulation (negative acute-phase reactant). By combining a marker that goes up with inflammation with one that tends to go down, the ratio summarizes overall systemic inflammatory burden and physiological stress, integrating immune activation with hepatic protein synthesis capacity.

Inflammatory drive versus protein reserve

The CRP/Albumin Ratio (CAR) reads how "hot" the body's immune response is while also gauging the blood's protein reserve. CRP rises quickly with inflammation and tissue injury; albumin falls when the liver shifts away from protein production or when protein is lost or diluted. Together, the ratio reflects the balance between inflammatory stress and nutritional/hepatic resilience, which matters for the heart, vessels, immune system, recovery from illness, and survival.

CAR combines two liver-made proteins to capture systemic stress. C‑reactive protein reflects innate immune activation and tissue injury (acute‑phase response). Albumin reflects the body's protein-making capacity, vascular protein reserve, and plasma volume (negative acute‑phase protein). Together, the ratio tracks inflammation relative to anabolic and nutritional status, linking to energy use, vascular health, recovery from illness, and overall resilience.

Reading a low, mid, or high CAR

Across labs, healthy people typically show a very low ratio; within reference ranges values tend toward the low end. Mid-range results can reflect minor, short-lived inflammation, while higher ratios suggest more substantial systemic stress. Trends over time are informative.

When the ratio is low, CRP is quiet and/or albumin is well maintained. This points to controlled immune activity, adequate protein status, stable liver synthesis, and intact vascular barriers. People usually feel well, with good energy, wound healing, and exercise tolerance. Children and teens commonly have low ratios. In late pregnancy, albumin runs lower from hemodilution, so even well-being may show a modestly higher ratio.

Low values usually reflect quiet immune activity with preserved liver protein synthesis and stable plasma volume. Physiology is in an anabolic, energy-efficient state with intact endothelial barrier and fluid balance. This pattern is common in younger, leaner adults; in late pregnancy, very low values are less typical because albumin is physiologically lower.

Being in range suggests balanced inflammatory tone and adequate protein reserves, supporting steady metabolism, cognition, and cardiovascular stability. In healthy populations, optimal tends to sit toward the lower end of the reference interval because CRP is near the assay's floor while albumin is normal.

A high ratio signals heightened inflammatory drive and/or low albumin from liver reprioritization, protein loss (kidney, gut), dilution, or malnutrition. It often accompanies fever, fatigue, decreased appetite, swelling of legs or eyelids, slower healing, and muscle loss. Higher CAR has been linked with more severe infections, autoimmune flares, surgical stress, cancer burden, and cardiovascular risk, particularly in older adults. Women can show slightly higher CRP on average, which may nudge the ratio upward.

High values usually reflect heightened inflammation and/or reduced albumin, as seen with infections, tissue injury, autoimmune activity, cancer-related inflammation, or chronic disease. IL‑6–driven CRP rises while albumin falls from reprioritized hepatic synthesis, dilution, or catabolic state, promoting insulin resistance, hypercoagulability, muscle breakdown, and endothelial dysfunction. Higher values are more common with aging, obesity, chronic liver or kidney disease, and in pregnancy (lower albumin and modest inflammatory tone).

Timing, drugs, and assay variation

CAR is influenced by acute illness timing, hydration, and assay differences. Estrogens can raise CRP; corticosteroids, NSAIDs, and statins can lower it. Albumin falls with inflammation, liver disease, nephrosis, or dilution. Reference ranges vary by lab and population.

Inflammation meets metabolism in a single ratio

CAR integrates immune activation (CRP) with liver function and nutrition (albumin), connecting inflammation to metabolism, vascular integrity, and recovery capacity. Persistently high ratios correlate with frailty, complications, and long-term cardiometabolic risk, while low ratios reflect resilient, well-regulated physiology.

FAQs

CAR testing measures CRP and albumin in blood and expresses them as a ratio to integrate inflammation and protein–nutritional status.

It quantifies systemic inflammation and protein status together, offering risk insight for recovery, cardiovascular health, and chronic inflammation.

Periodically, and around events such as illness, surgery, or lifestyle/training changes. Trends are more meaningful than single values.

Acute infections, chronic inflammation, body composition, trauma, medications, estrogen status, pregnancy, hydration, liver or kidney function, and protein intake.

Typically no fasting required. Hydrate well and avoid unusual strenuous exercise right before testing.

Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

References

  1. Lu, Z., Fu, S., Li, W., Gao, X., & Wang, J. (2024). Prognostic role of C-reactive protein to albumin ratio in lung cancer: An updated systematic review and meta-analysis. Chronic Diseases and Translational Medicine, 10(1), 31-39. https://doi.org/10.1002/cdt3.91
  2. Soeters, P. B., Wolfe, R. R., & Shenkin, A. (2019). Hypoalbuminemia: Pathogenesis and clinical significance. JPEN. Journal of Parenteral and Enteral Nutrition, 43(2), 181-193. https://doi.org/10.1002/jpen.1451
  3. Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2012). Human serum albumin: From bench to bedside. Molecular Aspects of Medicine, 33(3), 209-290. https://doi.org/10.1016/j.mam.2011.12.002
  4. He, J., Pan, H., Liang, W., Xiao, D., Chen, X., Guo, M., & He, J. (2017). Prognostic effect of albumin-to-globulin ratio in patients with solid tumors: A systematic review and meta-analysis. Journal of Cancer, 8(19), 4002-4010. https://doi.org/10.7150/jca.21141
  5. O'Connell, T. X., Horita, T. J., & Kasravi, B. (2005). Understanding and interpreting serum protein electrophoresis. American Family Physician, 71(1), 105-112. https://pubmed.ncbi.nlm.nih.gov/15663032/

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey